Software Solution for Payer - Medical / Health Care - Medical Monitoring
With Qynapse we all benefit from earlier and more accurate monitoring of patients. Patients, practitioners, researchers and you – the payer, all benefit from earlier, more accurate central nervous system disease diagnosis and monitoring of patients throughout the care continuum. Qynapse has the potential to help lower costs, drive up quality outcomes and improve patient satisfaction. Are you ready to transform neuroscience with us?
Details
The Qynapse team is on the forefront of neuroimaging and the early prognosis on progress is astounding. Our neuroimaging tool, QyScore®, has been implemented in US and EU clinics and is expanding soon into new global markets and used in multi-site clinical trials and global research collaborations.
When leveraged in a clinical setting, QyScore® provides objective and reliable measures to potentially improve the accuracy of diagnosis, precisely evaluate therapeutic impact and reliably measure disease progression. This also creates the potential for patients to experience a shorter time to diagnosis, fewer clinical visits and a more personalized therapeutic intervention. If these ends are achieved, this may lead to better patient outcomes, improved quality of life, and decreased costs over the CNS care pathway.
Our neuroimaging software platform, QyScore®:
- Provides precise, accurate, objective readouts that may decrease the likelihood of misdiagnosis, which may create transparency to more effectively and efficiently manage patient outcomes
- Creates the potential for better longitudinal monitoring of disease progression and therapeutic effectiveness, which may help to better manage costs and maximize outcomes
- Has demonstrated better performance when compared to certain other state-of-the-art automated methods on the market